Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells.
Market Analysis and Insights: Global Drug and Gene Delivery Systems Market
The global Drug and Gene Delivery Systems market size is projected to reach US$ 651580 million by 2026, from US$ 517570 million in 2020, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug and Gene Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug and Gene Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug and Gene Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug and Gene Delivery Systems market.
Drug and Gene Delivery Systems Breakdown Data by Type
Drug Delivery Systems
Gene Delivery Systems
Drug and Gene Delivery Systems Breakdown Data by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Based on regional and country-level analysis, the Drug and Gene Delivery Systems market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Drug and Gene Delivery Systems market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Market Analysis and Insights: Global Drug and Gene Delivery Systems Market
The global Drug and Gene Delivery Systems market size is projected to reach US$ 651580 million by 2026, from US$ 517570 million in 2020, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug and Gene Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug and Gene Delivery Systems market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug and Gene Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug and Gene Delivery Systems market.
Drug and Gene Delivery Systems Breakdown Data by Type
Drug Delivery Systems
Gene Delivery Systems
Drug and Gene Delivery Systems Breakdown Data by Application
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Based on regional and country-level analysis, the Drug and Gene Delivery Systems market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Drug and Gene Delivery Systems market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug and Gene Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Drug Delivery Systems
1.2.3 Gene Delivery Systems
1.3 Market by Application
1.3.1 Global Drug and Gene Delivery Systems Market Share by Application: 2020 VS 2026
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Ophthalmology
1.3.5 Urology
1.3.6 Diabetes
1.3.7 CNS
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug and Gene Delivery Systems Market Perspective (2015-2026)
2.2 Global Drug and Gene Delivery Systems Growth Trends by Regions
2.2.1 Drug and Gene Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug and Gene Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Drug and Gene Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery Systems Players by Market Size
3.1.1 Global Top Drug and Gene Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Drug and Gene Delivery Systems Revenue Market Share by Players (2015-2020)
3.2 Global Drug and Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug and Gene Delivery Systems Revenue
3.4 Global Drug and Gene Delivery Systems Market Concentration Ratio
3.4.1 Global Drug and Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery Systems Revenue in 2019
3.5 Key Players Drug and Gene Delivery Systems Area Served
3.6 Key Players Drug and Gene Delivery Systems Product Solution and Service
3.7 Date of Enter into Drug and Gene Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug and Gene Delivery Systems Breakdown Data by Type (2015-2026)
4.1 Global Drug and Gene Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Type (2021-2026)
5 Drug and Gene Delivery Systems Breakdown Data by Application (2015-2026)
5.1 Global Drug and Gene Delivery Systems Historic Market Size by Application (2015-2020)
5.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug and Gene Delivery Systems Market Size (2015-2026)
6.2 North America Drug and Gene Delivery Systems Market Size by Type (2015-2020)
6.3 North America Drug and Gene Delivery Systems Market Size by Application (2015-2020)
6.4 North America Drug and Gene Delivery Systems Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Drug and Gene Delivery Systems Market Size (2015-2026)
7.2 Europe Drug and Gene Delivery Systems Market Size by Type (2015-2020)
7.3 Europe Drug and Gene Delivery Systems Market Size by Application (2015-2020)
7.4 Europe Drug and Gene Delivery Systems Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Drug and Gene Delivery Systems Market Size (2015-2026)
8.2 China Drug and Gene Delivery Systems Market Size by Type (2015-2020)
8.3 China Drug and Gene Delivery Systems Market Size by Application (2015-2020)
8.4 China Drug and Gene Delivery Systems Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Drug and Gene Delivery Systems Market Size (2015-2026)
9.2 Japan Drug and Gene Delivery Systems Market Size by Type (2015-2020)
9.3 Japan Drug and Gene Delivery Systems Market Size by Application (2015-2020)
9.4 Japan Drug and Gene Delivery Systems Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Drug and Gene Delivery Systems Market Size (2015-2026)
10.2 Southeast Asia Drug and Gene Delivery Systems Market Size by Type (2015-2020)
10.3 Southeast Asia Drug and Gene Delivery Systems Market Size by Application (2015-2020)
10.4 Southeast Asia Drug and Gene Delivery Systems Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug and Gene Delivery Systems Introduction
11.1.4 Novartis Revenue in Drug and Gene Delivery Systems Business (2015-2020))
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Drug and Gene Delivery Systems Introduction
11.2.4 Amgen Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.2.5 Amgen Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Drug and Gene Delivery Systems Introduction
11.3.4 Oxford BioMedica Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.3.5 Oxford BioMedica Recent Development
11.4 SIBIONO
11.4.1 SIBIONO Company Details
11.4.2 SIBIONO Business Overview
11.4.3 SIBIONO Drug and Gene Delivery Systems Introduction
11.4.4 SIBIONO Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.4.5 SIBIONO Recent Development
11.5 Shanghai Sunway Biotech
11.5.1 Shanghai Sunway Biotech Company Details
11.5.2 Shanghai Sunway Biotech Business Overview
11.5.3 Shanghai Sunway Biotech Drug and Gene Delivery Systems Introduction
11.5.4 Shanghai Sunway Biotech Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.5.5 Shanghai Sunway Biotech Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Drug and Gene Delivery Systems Introduction
11.6.4 Roche Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.6.5 Roche Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Drug and Gene Delivery Systems Introduction
11.7.4 Pfizer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Drug and Gene Delivery Systems Introduction
11.8.4 Bayer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.8.5 Bayer Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Drug and Gene Delivery Systems Introduction
11.9.4 Johnson & Johnson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.9.5 Johnson & Johnson Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Details
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Drug and Gene Delivery Systems Introduction
11.10.4 Becton Dickinson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.10.5 Becton Dickinson Recent Development
11.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Drug and Gene Delivery Systems Introduction
10.11.4 AstraZeneca Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.11.5 AstraZeneca Recent Development
11.12 Baxter
10.12.1 Baxter Company Details
10.12.2 Baxter Business Overview
10.12.3 Baxter Drug and Gene Delivery Systems Introduction
10.12.4 Baxter Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.12.5 Baxter Recent Development
11.13 HSCI
10.13.1 HSCI Company Details
10.13.2 HSCI Business Overview
10.13.3 HSCI Drug and Gene Delivery Systems Introduction
10.13.4 HSCI Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.13.5 HSCI Recent Development
11.14 Epeius Biotechnologies
10.14.1 Epeius Biotechnologies Company Details
10.14.2 Epeius Biotechnologies Business Overview
10.14.3 Epeius Biotechnologies Drug and Gene Delivery Systems Introduction
10.14.4 Epeius Biotechnologies Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.14.5 Epeius Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug and Gene Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Drug Delivery Systems
1.2.3 Gene Delivery Systems
1.3 Market by Application
1.3.1 Global Drug and Gene Delivery Systems Market Share by Application: 2020 VS 2026
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Ophthalmology
1.3.5 Urology
1.3.6 Diabetes
1.3.7 CNS
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug and Gene Delivery Systems Market Perspective (2015-2026)
2.2 Global Drug and Gene Delivery Systems Growth Trends by Regions
2.2.1 Drug and Gene Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug and Gene Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Drug and Gene Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery Systems Players by Market Size
3.1.1 Global Top Drug and Gene Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Drug and Gene Delivery Systems Revenue Market Share by Players (2015-2020)
3.2 Global Drug and Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug and Gene Delivery Systems Revenue
3.4 Global Drug and Gene Delivery Systems Market Concentration Ratio
3.4.1 Global Drug and Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery Systems Revenue in 2019
3.5 Key Players Drug and Gene Delivery Systems Area Served
3.6 Key Players Drug and Gene Delivery Systems Product Solution and Service
3.7 Date of Enter into Drug and Gene Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug and Gene Delivery Systems Breakdown Data by Type (2015-2026)
4.1 Global Drug and Gene Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Type (2021-2026)
5 Drug and Gene Delivery Systems Breakdown Data by Application (2015-2026)
5.1 Global Drug and Gene Delivery Systems Historic Market Size by Application (2015-2020)
5.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drug and Gene Delivery Systems Market Size (2015-2026)
6.2 North America Drug and Gene Delivery Systems Market Size by Type (2015-2020)
6.3 North America Drug and Gene Delivery Systems Market Size by Application (2015-2020)
6.4 North America Drug and Gene Delivery Systems Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Drug and Gene Delivery Systems Market Size (2015-2026)
7.2 Europe Drug and Gene Delivery Systems Market Size by Type (2015-2020)
7.3 Europe Drug and Gene Delivery Systems Market Size by Application (2015-2020)
7.4 Europe Drug and Gene Delivery Systems Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Drug and Gene Delivery Systems Market Size (2015-2026)
8.2 China Drug and Gene Delivery Systems Market Size by Type (2015-2020)
8.3 China Drug and Gene Delivery Systems Market Size by Application (2015-2020)
8.4 China Drug and Gene Delivery Systems Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Drug and Gene Delivery Systems Market Size (2015-2026)
9.2 Japan Drug and Gene Delivery Systems Market Size by Type (2015-2020)
9.3 Japan Drug and Gene Delivery Systems Market Size by Application (2015-2020)
9.4 Japan Drug and Gene Delivery Systems Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Drug and Gene Delivery Systems Market Size (2015-2026)
10.2 Southeast Asia Drug and Gene Delivery Systems Market Size by Type (2015-2020)
10.3 Southeast Asia Drug and Gene Delivery Systems Market Size by Application (2015-2020)
10.4 Southeast Asia Drug and Gene Delivery Systems Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug and Gene Delivery Systems Introduction
11.1.4 Novartis Revenue in Drug and Gene Delivery Systems Business (2015-2020))
11.1.5 Novartis Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Drug and Gene Delivery Systems Introduction
11.2.4 Amgen Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.2.5 Amgen Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Drug and Gene Delivery Systems Introduction
11.3.4 Oxford BioMedica Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.3.5 Oxford BioMedica Recent Development
11.4 SIBIONO
11.4.1 SIBIONO Company Details
11.4.2 SIBIONO Business Overview
11.4.3 SIBIONO Drug and Gene Delivery Systems Introduction
11.4.4 SIBIONO Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.4.5 SIBIONO Recent Development
11.5 Shanghai Sunway Biotech
11.5.1 Shanghai Sunway Biotech Company Details
11.5.2 Shanghai Sunway Biotech Business Overview
11.5.3 Shanghai Sunway Biotech Drug and Gene Delivery Systems Introduction
11.5.4 Shanghai Sunway Biotech Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.5.5 Shanghai Sunway Biotech Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Drug and Gene Delivery Systems Introduction
11.6.4 Roche Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.6.5 Roche Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Drug and Gene Delivery Systems Introduction
11.7.4 Pfizer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Drug and Gene Delivery Systems Introduction
11.8.4 Bayer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.8.5 Bayer Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Drug and Gene Delivery Systems Introduction
11.9.4 Johnson & Johnson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.9.5 Johnson & Johnson Recent Development
11.10 Becton Dickinson
11.10.1 Becton Dickinson Company Details
11.10.2 Becton Dickinson Business Overview
11.10.3 Becton Dickinson Drug and Gene Delivery Systems Introduction
11.10.4 Becton Dickinson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
11.10.5 Becton Dickinson Recent Development
11.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Drug and Gene Delivery Systems Introduction
10.11.4 AstraZeneca Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.11.5 AstraZeneca Recent Development
11.12 Baxter
10.12.1 Baxter Company Details
10.12.2 Baxter Business Overview
10.12.3 Baxter Drug and Gene Delivery Systems Introduction
10.12.4 Baxter Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.12.5 Baxter Recent Development
11.13 HSCI
10.13.1 HSCI Company Details
10.13.2 HSCI Business Overview
10.13.3 HSCI Drug and Gene Delivery Systems Introduction
10.13.4 HSCI Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.13.5 HSCI Recent Development
11.14 Epeius Biotechnologies
10.14.1 Epeius Biotechnologies Company Details
10.14.2 Epeius Biotechnologies Business Overview
10.14.3 Epeius Biotechnologies Drug and Gene Delivery Systems Introduction
10.14.4 Epeius Biotechnologies Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.14.5 Epeius Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
